RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Vifor Pharma Stock

Vifor Pharma Dividend 2024

Vifor Pharma Dividend

2.82 CHF

Vifor Pharma Dividend yield

1.2 %

Ticker

VIFN.SW

ISIN

CH0364749348

WKN

A2DRZ4

How much dividend does Vifor Pharma 2024 pay?

According to the latest status from December 2024, Vifor Pharma paid a total of 2.82 CHF per share in dividends within the last 12 months. With the current Vifor Pharma price of 166.15 CHF, this corresponds to a dividend yield of 1.7 %. A dividend is paid 1 times per year.

1.2 % Dividend Yield=
2 CHF Dividend
166.15 CHF Stock Price

Historical Vifor Pharma Dividends

A dividend is paid 1 times per year. Last year, the payout months were and .

PaydateDividend
5/29/20222
6/10/20212
6/18/20202
6/10/20192
6/17/20182
6/16/201720
6/3/201618
6/12/201515
6/13/201414
6/6/201311
6/7/20129
6/9/20118
6/11/20107.5
6/19/20097
6/14/20086
6/30/20075
6/23/20064.3
9/15/20053.9
7/3/20043.6
6/28/20033.3
1

Vifor Pharma dividend history and estimates

In 2023, Vifor Pharma paid a dividend amounting to 2.82 CHF. Dividend means that Vifor Pharma distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Vifor Pharma provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Vifor Pharma’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Vifor Pharma's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Vifor Pharma Dividend History

DateVifor Pharma Dividend
2026e7.47 undefined
2025e6.28 undefined
2024e3.77 undefined
2023e2.82 undefined
2022e2.57 undefined
20212 undefined
20202 undefined
20192 undefined
20182 undefined
20172 undefined
20161.8 undefined
20151.5 undefined
20141.4 undefined
20131.1 undefined
20120.9 undefined
20110.8 undefined
20100.75 undefined
20090.7 undefined
20080.6 undefined
20070.5 undefined
20060.43 undefined
20050.39 undefined
20040.36 undefined
20030.33 undefined

Is the Vifor Pharma Dividend Safe?

Vifor Pharma has been increasing the dividend for 1 years.

Over the past 10 years, Vifor Pharma has increased it by an annual 9.596 %.

Over a five-year period, the distribution increased by 2.13%.

Analysts expect a Dividend Increase of 13.32% for the current fiscal year.

Vifor Pharma dividend payout ratio

In 2023, Vifor Pharma had a payout ratio of 65.23%. The payout ratio indicates the percentage of the company's profits that Vifor Pharma distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Vifor Pharma represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Vifor Pharma could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Vifor Pharma's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Vifor Pharma Payout Ratio History

DateVifor Pharma Payout ratio
2026e69.98 %
2025e69.83 %
2024e74.89 %
2023e65.23 %
2022e69.36 %
202190.09 %
202036.23 %
201981.77 %
201885.32 %
201711.33 %
201649.32 %
201532.34 %
201431.93 %
201324.12 %
201223.08 %
201123.26 %
201021.19 %
200921.6 %
200820.62 %
200724.27 %
200627.04 %
200531.45 %
200430.25 %
200332.04 %
200269.36 %

Dividend Details

Understanding Vifor Pharma's Dividend Distributions

Vifor Pharma’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Vifor Pharma's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Vifor Pharma's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Vifor Pharma’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Vifor Pharma Aktienanalyse

What does Vifor Pharma do?

Vifor Pharma AG is a leading pharmaceutical company based in St. Gallen, Switzerland. The company has a long history and over 100 years of experience in the manufacturing of pharmaceutical products. It was founded in 1872 as Etablissements Gallois and has undergone various mergers and acquisitions. Today, it is part of the global Galenica Group and has branches in over 30 countries. Vifor Pharma AG focuses on the development and production of medications for the treatment of iron deficiency and kidney diseases. It diversifies its business across different market segments and geographic regions. The company's well-known products include iron preparations sold under different brands such as Ferinject, Injectafer, and Venofer, used for the treatment of iron deficiency anemia in both intravenous and tablet forms. another important business area for Vifor Pharma AG is nephrology, with a wide range of kidney and dialysis products available, including treatments for hyperphosphatemia and anemia in dialysis patients. To strengthen its innovation, the company has invested in partnerships, such as an exclusive license for the distribution of Vadadustat, an oral medication for the treatment of anemia in chronic kidney disease. Vifor Pharma AG has also invested in the digitalization and data-driven technologies, acquiring a stake in the Austrian company medisign GmbH in 2020 to expand its expertise in digital health and telemedicine. In terms of sustainability, the company aims to be carbon-neutral by 2025 and has implemented measures to reduce its CO2 footprint. With its long history, diverse portfolio of products and services, and investments in innovation and sustainability, Vifor Pharma AG is well-positioned for future success. Vifor Pharma is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Vifor Pharma stock

How much dividend does Vifor Pharma pay?

Over the past 12 months, Vifor Pharma paid a dividend of 2 CHF . This corresponds to a dividend yield of about 1.2 %. For the coming 12 months, Vifor Pharma is expected to pay a dividend of 6.28 CHF.

What is the dividend yield of Vifor Pharma?

The current dividend yield of Vifor Pharma is 1.2 %.

When does Vifor Pharma pay dividends?

Vifor Pharma pays a quarterly dividend. This is distributed in the months of June, June, June, May.

How secure is the dividend of Vifor Pharma?

Vifor Pharma paid dividends every year for the past 24 years.

What is the dividend of Vifor Pharma?

For the upcoming 12 months, dividends amounting to 6.28 CHF are expected. This corresponds to a dividend yield of 3.78 %.

In which sector is Vifor Pharma located?

Vifor Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Vifor Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vifor Pharma from 5/3/2022 amounting to 2 CHF, you needed to have the stock in your portfolio before the ex-date on 4/29/2022.

When did Vifor Pharma pay the last dividend?

The last dividend was paid out on 5/3/2022.

What was the dividend of Vifor Pharma in the year 2023?

In the year 2023, Vifor Pharma distributed 2 CHF as dividends.

In which currency does Vifor Pharma pay out the dividend?

The dividends of Vifor Pharma are distributed in CHF.

Andere Kennzahlen von Vifor Pharma

Our stock analysis for Vifor Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vifor Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.